Harvard Licensing Deal Reflects Its 'Public Mission'

Harvard University, one of the originators of a statement of how institutions can serve the public good while commercializing technology, has taken the message to heart.

A deal that the university has just signed for licensing a new vaccine technology, a top official says, reflects many of the principles espoused in the statement.

The invention involves a biochemical method of producing vaccines that could prove to be less complex than many existing approaches.

The

Print Subscription

Digital Subscription

Already have an account? Log In Now.